2m 2m 2m 2m 2m 2m 2m
- $1.9BMarket Cap
- 102.23%1-Year Change
- Medical Care FacilitiesIndustry
AGILON HEALTH (AGL)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 77
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
These ETFs Owned Russell 2000's Biggest Winners Before They Soared 400%+ In 2026
Several Russell 2000 small-cap stocks have surged 400%+ in 2026, driven by AI infrastructure demand. Companies like Applied Optoelectronics, Aehr Test Systems, and MaxLinear—which supply optical networking, semiconductor testing, and connectivity products—have outperformed mega-cap tech stocks. Small-cap growth ETFs including VTWG, IWO, and ISMD provided early exposure to these winners before they became mainstream AI investment stories.
06/03/2026, 2:54 PM • Benzinga
Micron And Dell Are Up 260%: These 5 Small Caps Nearly Doubled That
While Micron and Dell have surged 260% in 2026 driven by AI server demand, five Russell 2000 small-cap stocks have each rallied over 400%. Four are AI supply chain plays (optical components, semiconductor testing, networking chips), while one is an unrelated healthcare company. Applied Optoelectronics leads at +473%, followed by Rackspace at +461%, Aehr Test Systems at +436%, agilon health at +404%, and MaxLinear at +398%.
06/02/2026, 10:56 AM • Benzinga
7 Small-Cap Stocks More Than Doubled In May: Micron Did Only 46%
Seven Russell 2000 small-cap stocks more than doubled in May 2026, significantly outperforming Micron Technology's 46% gain. The rallies were driven by specific catalysts including strong earnings reports, guidance raises, strategic partnerships, and defense contracts. Hyliion Holdings led with a 213.6% gain, followed by Agilon Health at 209.1%, with each company benefiting from positive business developments and analyst upgrades.
05/25/2026, 2:16 PM • Benzinga
Law firm Levi & Korsinsky notifies investors of class action securities lawsuits against agilon health, inc., Ardent Health, Inc., and Zynex, Inc. The primary case involves agilon health for alleged securities fraud between February 26, 2025 and August 4, 2025, with claims that defendants issued false 2025 guidance and overstated financial impacts from strategic actions. Lead plaintiff deadlines range from March 2 to April 21, 2026.
03/02/2026, 4:00 PM • GlobeNewswire
The Law Offices of Frank R. Cruz has announced class action lawsuits against four publicly-traded companies for allegedly making materially false and misleading statements to investors. Agilon Health is accused of issuing unachievable 2025 guidance; Fermi Inc. of overstating tenant demand for Project Matador; Varonis Systems of failing to disclose growth trajectory challenges; and Ardent Health of misrepresenting accounts receivable practices and insurance coverage. Lead plaintiff deadlines range from March 2-9, 2026.
03/02/2026, 10:48 AM • GlobeNewswire
A class action lawsuit has been filed against Agilon Health, Inc. (NYSE: AGL) for allegedly making false and misleading statements regarding 2025 guidance and overstating financial impacts from strategic actions. Investors who purchased Agilon securities between February 26, 2025 and August 4, 2025 have until March 2, 2026 to apply as lead plaintiff.
03/01/2026, 6:17 PM • GlobeNewswire
A class action lawsuit has been filed against agilon health, inc. alleging that company executives made false and misleading statements regarding 2026 guidance and overstated the financial impact of strategic risk reduction actions during the period from February 26, 2025 to August 4, 2025. Investors who purchased agilon securities during this period are encouraged to join the case, with a lead plaintiff deadline of March 2, 2026.
02/27/2026, 12:00 PM • GlobeNewswire
A class action lawsuit has been filed against Agilon Health, Inc. for allegedly making false and misleading statements regarding 2025 guidance and overstating financial impacts from strategic actions. Investors who purchased Agilon securities between February 26, 2025 and August 4, 2025 have until March 2, 2026 to apply as lead plaintiff.
02/24/2026, 5:43 PM • GlobeNewswire
Pomerantz Law Firm has filed class action lawsuits against agilon health, inc. and other companies for alleged securities fraud. Agilon's CEO stepped down on August 4, 2025, and the company suspended its 2025 financial guidance, citing acute industry headwinds. The stock fell 51.52% to $0.88 per share on August 5, 2025. Investors have until March 2, 2026 to request Lead Plaintiff status.
02/24/2026, 4:52 PM • GlobeNewswire
Rosen Law Firm is soliciting investors who purchased securities in PomDoctor Ltd., Richtech Robotics Inc., and agilon health, inc. during specified periods to join class action lawsuits. The firm alleges that PomDoctor was subject to fraudulent stock promotion schemes and misleading statements, while similar allegations are being pursued against the other companies. The lead plaintiff deadline for PomDoctor is April 7, 2026.
02/21/2026, 9:50 AM • GlobeNewswire
Rosen Law Firm has filed securities class action lawsuits against Richtech Robotics Inc. (RR), PomDoctor Ltd. (POM), and agilon health, inc. (AGL). The primary case involves Richtech Robotics, which allegedly made false statements about having a collaborative relationship with Microsoft. Investors who purchased securities during specified class periods are encouraged to seek counsel before upcoming deadlines, with the lead plaintiff deadline for Richtech set for April 3, 2026.
02/21/2026, 9:31 AM • GlobeNewswire
Rosen Law Firm is soliciting investors who purchased securities of Agilon Health (AGL) between February 26, 2025 and August 4, 2025 to join a securities class action lawsuit. The firm alleges that Agilon made false and misleading statements regarding 2025 guidance, overstated financial impacts from strategic actions, and failed to disclose material industry headwinds. The lead plaintiff deadline is March 2, 2026. Similar class action notices are being issued for Beyond Meat and Phoenix Education Partners.
02/21/2026, 8:45 AM • GlobeNewswire
A class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) alleging that company executives made false and misleading statements regarding 2026 guidance and overstated the financial impact of strategic risk-reduction actions. The lawsuit covers investors who purchased agilon securities between February 26, 2025 and August 4, 2025. The lead plaintiff deadline is March 2, 2026.
02/20/2026, 12:00 PM • GlobeNewswire
A securities fraud class action lawsuit has been filed against agilon health, inc. for allegedly issuing false 2025 guidance and overstating the impact of strategic actions despite known industry headwinds. The CEO was terminated without cause on August 4, 2025, the same day the company suspended its full-year 2025 financial guidance. The stock price declined 51.6% following the announcement. Investors have until March 2, 2026 to apply to be lead plaintiff.
02/19/2026, 6:00 PM • GlobeNewswire
Class action lawsuits have been filed against Klarna Group, agilon health, and Fermi Inc. for alleged securities fraud involving false statements and material omissions. Klarna faces allegations of understating loss reserve risks post-IPO, agilon is accused of issuing unachievable 2025 guidance, and Fermi is charged with overstating tenant demand for its Project Matador campus. Lead plaintiff deadlines range from February 20 to March 6, 2026.
02/19/2026, 1:50 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/23/2026
Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Key Executives
- Jeffrey Alan Schwaneke
- Benjamin Shaker
- Denise Zamore
- Girish Venkatachaliah
- Karthik Rao
Current Ownership Distribution
- Institutions7.3B (67.29%)
- Mutual Funds3.5B (31.75%)
- Insiders104.3M (0.96%)
- Other0 (0.00%)